Rowe, Peter S. N.

Degradation of MEPE, DMP1, and release of SIBLING ASARM-Peptides (Minhibins): ASARM-Peptide(s) are directly responsible for defective mineralization in HYP

Martin, A., David, V., Laurence, J. S., Schwarz, P. M., Lafer, E. M., Hedge, A.-M., & Rowe, P. S. N. (2008) · Endocrinology

Parathyroid Disorders and TreatmentsBone and Dental Protein Studies

Cited by 173

Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway

Rowe, P. S. N. (2012) · Critical Reviews™ in Eukaryotic Gene Expression

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 173

Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)

Rowe, P. S. N., Garrett, I. R., Schwarz, P. M., Carnes, D. L., Lafer, E. M., Mundy, G. R., & Gutierrez, G. E. (2005) · Bone

Parathyroid Disorders and TreatmentsBone and Dental Protein Studies

Cited by 149

Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator

David, V., Martin, A., Hedge, A.-M., & Rowe, P. S. N. (2009) · Endocrinology

Parathyroid Disorders and TreatmentsAlkaline Phosphatase Research Studies

Cited by 106